Switch theme
Sign up to access all valuation multiples
Chularat Hospital PCL operates hospitals and clinics in Thailand. The company operates through several branches of clinics and hospitals. Additionally, it distributed medical instruments and dietary supplements to customers in Thailand. The Group have two reportable segments that are hospital operations and other businesses that support hospital business including distribution of medical instruments. A majority of the company's revenue is derived from hospital operations, consisting of medical fees, medicine sales, and hospital room sales.
1986
n/a
LTM Revenue $249M
LTM EBITDA $52.7M
$713M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Chularat Hospital has a last 12-month revenue of $249M and a last 12-month EBITDA of $52.7M.
In the most recent fiscal year, Chularat Hospital achieved revenue of $229M and an EBITDA of $53.7M.
Chularat Hospital expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chularat Hospital valuation multiples based on analyst estimates| FY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $299M | $229M | $246M | $249M | XXX |
| Gross Profit | $174M | $124M | $59.5M | XXX | XXX |
| Gross Margin | 58% | 54% | 24% | XXX | XXX |
| EBITDA | $117M | $53.7M | $51.5M | $52.7M | XXX |
| EBITDA Margin | 39% | 23% | 21% | 21% | XXX |
| Net Profit | $125M | $82.3M | $31.0M | XXX | XXX |
| Net Margin | 42% | 36% | 13% | XXX | XXX |
| Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Chularat Hospital's stock price is THB 2 (or $0).
Chularat Hospital has current market cap of THB 25.1B (or $743M), and EV of THB 24.1B (or $713M).
See Chularat Hospital trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $713M | $743M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Chularat Hospital has market cap of $743M and EV of $713M.
Chularat Hospital's trades at 2.9x LTM EV/Revenue multiple, and 13.5x LTM EBITDA.
Analysts estimate Chularat Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Chularat Hospital and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $713M | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 13.8x | XXX | XXX | XXX |
| P/E | 23.3x | XXX | XXX | XXX |
| P/E/Growth | 1.8x | XXX | XXX | XXX |
| EV/FCF | 22.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpChularat Hospital's NTM/LTM revenue growth is 9%
Chularat Hospital's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Chularat Hospital's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Chularat Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Chularat Hospital and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -4% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 30% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 8% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chularat Hospital acquired XXX companies to date.
Last acquisition by Chularat Hospital was XXXXXXXX, XXXXX XXXXX XXXXXX . Chularat Hospital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Chularat Hospital founded? | Chularat Hospital was founded in 1986. |
| Where is Chularat Hospital headquartered? | Chularat Hospital is headquartered in Thailand. |
| Who is the CEO of Chularat Hospital? | Chularat Hospital's CEO is Dr. Jedsada Chokdamrongsuk. |
| Is Chularat Hospital publicy listed? | Yes, Chularat Hospital is a public company listed on BKK. |
| What is the stock symbol of Chularat Hospital? | Chularat Hospital trades under CHG ticker. |
| When did Chularat Hospital go public? | Chularat Hospital went public in 2013. |
| Who are competitors of Chularat Hospital? | Similar companies to Chularat Hospital include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Chularat Hospital? | Chularat Hospital's current market cap is $743M |
| What is the current revenue of Chularat Hospital? | Chularat Hospital's last 12-month revenue is $249M. |
| What is the current EBITDA of Chularat Hospital? | Chularat Hospital's last 12-month EBITDA is $52.7M. |
| What is the current EV/Revenue multiple of Chularat Hospital? | Current revenue multiple of Chularat Hospital is 2.9x. |
| What is the current EV/EBITDA multiple of Chularat Hospital? | Current EBITDA multiple of Chularat Hospital is 13.5x. |
| What is the current revenue growth of Chularat Hospital? | Chularat Hospital revenue growth between 2023 and 2024 was 7%. |
| Is Chularat Hospital profitable? | Yes, Chularat Hospital is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
